The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
MicroRNA-223 Antagonizes Angiogenesis by Targeting β1 Integrin and Preventing Growth Factor Signaling in Endothelial Cells
Abstract
Rationale: Endothelial cells in situ are largely quiescent, and their isolation and culture are associated with the switch to a proliferative phenotype. Objective: To identify antiangiogenic microRNAs expressed by native endothelial cells that are altered after isolation and culture, as well as the protein targets that regulate responses to growth factors. Methods and Results: Profiling studies revealed that miR-223 was highly expressed in freshly isolated human, murine, and porcine endothelial cells, but those levels decreased in culture. In primary cultures of endothelial cells, vascular endothelial cell growth factor and basic fibroblast growth factor further decreased miR-223 expression. The overexpression of precursor-miR-223 did not affect basal endothelial cell proliferation but abrogated vascular endothelial cell growth factor–induced and basic fibroblast growth factor–induced proliferation, as well as migration and sprouting. Inhibition of miR-223 in vivo using specific antagomirs potentiated postnatal retinal angiogenesis in wild-type mice, whereas recovery of perfusion after femoral artery ligation and endothelial sprouting from aortic rings from adult miR-223 −/y animals were enhanced. MiR-223 overexpression had no effect on the growth factor–induced activation of ERK1/2 but inhibited the vascular endothelial cell growth factor–induced and basic fibroblast growth factor–induced phosphorylation of their receptors and activation of Akt. β1 integrin was identified as a target of miR-223 and its downregulation reproduced the defects in growth factor receptor phosphorylation and Akt signaling seen after miR-223 overexpression. Reintroduction of β1 integrin into miR-223–ovexpressing cells was sufficient to rescue growth factor signaling and angiogenesis. Conclusions: These results indicate that miR-223 is an antiangiogenic microRNA that prevents endothelial cell proliferation at least partly by targeting β1 integrin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, miR-223 could target β1 integrin to prevent endothelial cell proliferation 59.”
From miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation (2021) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zovein, A. C., Luque, A., Turlo, K. A., Hofmann, J. J., Yee, K. M., Becker, M. S., Fassler, R., Mellman, I., Lane, T. F., & Iruela-Arispe, M. L. (2010) · Developmental Cell · doi:10.1016/j.devcel.2009.12.006 · Cited by 256
Differential expression of microRNAs in hematopoietic cell lineages
Merkerova, M., Belickova, M., & Bruchova, H. (2008) · European Journal of Haematology · doi:10.1111/j.1600-0609.2008.01111.x · Cited by 240
Research works printed but not linked: 34
- 10.1038/bjc.1984.66 · DOI · Paper page
- 10.1097/MOH.0b013e328345a180 · DOI
- 10.1161/circresaha.108.192872 · DOI · Paper page
- 10.1161/atvbaha.112.300142 · DOI
- 10.1074/jbc.M110.136168 · DOI · Paper page
- 10.2337/db10-1557 · DOI · Paper page
- 10.1074/jbc.M112.364414 · DOI
- 10.1371/journal.pone.0007629 · DOI · Paper page
- 10.1016/j.ccr.2008.10.005 · DOI · Paper page
- 10.1016/j.devcel.2008.07.008 · DOI · Paper page
- 10.1242/dev.029736 · DOI · Paper page
- 10.1016/j.devcel.2008.07.002 · DOI · Paper page
- 10.1038/nature08889 · DOI · Paper page
- 10.1161/atvbaha.111.236521 · DOI · Paper page
- 10.1161/circresaha.107.153916 · DOI · Paper page
- 10.1126/science.1174381 · DOI · Paper page
- 10.1038/nature06607 · DOI · Paper page
- 10.1016/j.cell.2005.09.023 · DOI · Paper page
- 10.1021/pr015509n · DOI · Paper page
- 10.1093/nar/gkp870 · DOI
- 10.1101/gad.1134603 · DOI · Paper page
- 10.1371/journal.pone.0016979 · DOI · Paper page
- 10.1186/2045-824X-4-1 · DOI
- 10.1038/nsmb.1651 · DOI · Paper page
- 10.1182/blood-2013-03-492801 · DOI · Paper page
- 10.1016/j.molcel.2010.06.010 · DOI · Paper page
- 10.1182/blood-2011-08-374793 · DOI · Paper page
- 10.1161/01.res.0000265065.26744.17 · DOI · Paper page
- 10.1242/dev.016378 · DOI · Paper page
- 10.1083/jcb.200906044 · DOI · Paper page
- 10.1074/jbc.M111.304972 · DOI
- 10.1161/circresaha.110.217257 · DOI
- 10.1161/circresaha.110.226357 · DOI · Paper page
- 10.1016/j.jacc.2012.03.056 · DOI · Paper page
Cited by
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells
Tabet, F., Vickers, K. C., Cuesta Torres, L. F., Wiese, C. B., Shoucri, B. M., Lambert, G., Catherinet, C., Prado-Lourenco, L., Levin, M. G., Thacker, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms4292 · Cited by 428
Circulating microRNAs as novel biomarkers for platelet activation.
Willeit, P., Zampetaki, A., Dudek, K., Kaudewitz, D., King, A., Kirkby, N. S., Crosby-Nwaobi, R., Prokopi, M., Drozdov, I., Langley, S. R., et al. (2013) · Circulation Research · doi:10.1161/circresaha.111.300539 · Cited by 365
He, Y., Rodrigues, R. M., Wang, X., Seo, W., Ma, J., Hwang, S., Fu, Y., Trojnár, E., Mátyás, C., Zhao, S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci141513 · Cited by 165
miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation
Jiao, P., Wang, X.-P., Luoreng, Z.-M., Yang, J., Jia, L., Ma, Y., & Wei, D.-W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59876 · Cited by 151
Awwad, K., Hu, J., Shi, L., Mangels, N., Abdel Malik, R., Zippel, N., Fisslthaler, B., Eble, J. A., Pfeilschifter, J., Popp, R., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv098 · Cited by 77
Self-citation
Metadata
- Authors
- Shi, L., Fisslthaler, B., Zippel, N., Frömel, T., Hu, J., Elgheznawy, A., Heide, H., Popp, R., & Fleming, I.
- Affiliations
- From the Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University and DZHK (German Centre for Cardiovascular Research) partner site Rhine-Main, Frankfurt, Germany (L.S., B.F., N.Z., T.F., J.H., A.E., R.P., I.F.); and Functional Proteomics, SFB 815 Core Unit, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany (H.H.).
- Venue
- Circulation Research
- Published
- 2013-12-06
- Volume
- 113
- Issue
- 12
- Pages
- 1320-1330
- ISSN
- 0009-7330
- 1524-4571
- Cited by
- 121
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MicroRNA-223 Antagonizes Angiogenesis by Targeting β1 Integrin and Preventing Growth Factor Signaling in Endothelial Cells. https://app.cochat.ai/papers/10.1161/circresaha.113.301824
- The paper
- Shi, L., Fisslthaler, B., Zippel, N., Frömel, T., Hu, J., Elgheznawy, A., Heide, H., Popp, R., & Fleming, I. (2013). MicroRNA-223 Antagonizes Angiogenesis by Targeting β1 Integrin and Preventing Growth Factor Signaling in Endothelial Cells. Circulation Research. https://doi.org/10.1161/circresaha.113.301824
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.